Real-World Safety of Nemolizumab: A Pharmacovigilance Analysis Using the FDA Adverse Event Reporting System (FAERS).

HOME
>
論文・技術情報
>
Real-World Safety of Nemolizumab: A Pharmacovigilance Analysis Using the FDA Adverse Event Reporting System (FAERS).

アブストラクト
ジャーナル名	Journal of the American Academy of Dermatology
Pubmed追加日	2026/5/29
投稿者	Sun, Mao-Ling; Wang, Si-Wen; Gao, Yun-Qiu; Chen, Zhi-Yuan; Liu, Xin-De; Gao, Xing-Hua; Guo, Ya-Xin
組織名	Department of Dermatology, The First Hospital of China Medical University,;Shenyang, China; Key Laboratory of Immunodermatology, Ministry of Education, and;National Health Commission; National Joint Engineering Research Center for;Theranostics of Immunological Skin Diseases, Shenyang, China. Electronic address:;274069045@qq.com.;2697544015@qq.com.;gaoyunqiu@qq.com.;zychen6868@163.com.;Department of General Surgery, The Fourth Affiliated Hospital of China Medical;University, Shenyang, China; Key Laboratory of Precision Prevention and Treatment;for Obesity and Metabolic Diseases, China Medical University, Shenyang, Liaoning,;China. Electronic address: liuxinde@cmu.edu.cn.;gaobarry@hotmail.com.;2452591392@qq.com.
Pubmed リンク	https://www.ncbi.nlm.nih.gov/pubmed/42208626/